USP7 and cancer: Another promising approach to stabilizing p53 in cancer cells consists of promoting the MDM2 proteasomal degradation through the Ub variant (UbV)-mediated inhibition of USP7 and USP2a deubiquitinases, known to be involved in stabilizing MDM2.